Lapis ISSN 2398-2969

Nalbuphine

Contributor(s): Molly Varga, Anna Meredith

Introduction

Name

  • Nalbuphine.

Class of drug

  • Opioid analgesic.
  • Opioid reversal agent.
  • Opioid agonist/antagonist.

Description

Chemical name

  • ()-17-(cyclobutylmethyl)- 4,5alpha-epoxymorphinan-3,6alpha,14-triol hydrochloride.

Molecular formula

  • C21H27NO4.

Molecular weight

  • 357.44.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Analgesia.
  • Narcotic reversal agent.
  • Antagonization of some of the adverse effects of pre-administered opioid agonists without complete reversal of analgesia (sequential analgesia).

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmocokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

Barbiturate anesthetics, phenothiazines and tranquilizers
  • May enhance nalbuphine's respiratory and central nervous depression.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

Other sources of information

  • Ramsey I (2014)BSAVA Small Animal Formulary.8th edn. BSAVA. ISBN: 9781905319657.
  • Veterinary Medicines Directorate (2013)Veterinary Medicines Guidance Notes.Website:www.gov.uk/government/collections/veterinary-medicines-guidance-notes-vmgns.
  • Hawk C T & Leary S (1995)Formulary for Laboratory Animals.Compiled in association with ACLAM (1995). Iowa State University Press, Ames.

Organisation(s)


ADDED